Home The Word Brain | My Amedeo FAQ Privacy About | ||||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
Drug Resistance |
Free Subscription
11 Antimicrob Agents Chemother |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Drug Resistance is free of charge.
Development of rabbit models of ventilator-associated bacterial pneumonia
produced by carbapenem-resistant Pseudomonas aeruginosa.
Antimicrob Agents Chemother. 2024 Apr 30:e0020524. doi: 10.1128/aac.00205.
PubMed
Abstract available
Vancomycin heteroresistance caused by unstable tandem amplifications of the vanM
gene cluster on linear conjugative plasmids in a clinical Enterococcus faecium.
Antimicrob Agents Chemother. 2024 Mar 20:e0115923. doi: 10.1128/aac.01159.
PubMed
Abstract available
Clinical and genomic characteristics of IMP-producing Enterobacter cloacae
complex and Klebsiella pneumoniae.
Antimicrob Agents Chemother. 2024;68:e0167223.
PubMed
Abstract available
Quorum-sensing regulation of phenazine production heightens Pseudomonas
aeruginosa resistance to ciprofloxacin.
Antimicrob Agents Chemother. 2024;68:e0011824.
PubMed
Abstract available
In vitro development of resistance against antipseudomonal agents: comparison of
novel beta-lactam/beta-lactamase inhibitor combinations and other beta-lactam agents.
Antimicrob Agents Chemother. 2024;68:e0136323.
PubMed
Abstract available
Exploring the links between SOS response, mutagenesis, and resistance during the
recovery period.
Antimicrob Agents Chemother. 2024;68:e0146223.
PubMed
Abstract available
The Ptk2-Pma1 pathway enhances tolerance to terbinafine in Trichophyton rubrum.
Antimicrob Agents Chemother. 2024;68:e0160923.
PubMed
Abstract available
Characterization of Acinetobacter baumannii-calcoaceticus complex isolates and
microbiological outcome for patients treated with sulbactam-durlobactam in a
phase 3 trial (ATTACK).
Antimicrob Agents Chemother. 2024;68:e0169823.
PubMed
Abstract available
Difficult-to-treat (DTR) Pseudomonas aeruginosa harboring Verona-Integron
metallo-beta-lactamase (bla(VIM)): infection management and molecular analysis.
Antimicrob Agents Chemother. 2024;68:e0147423.
PubMed
Abstract available
Combination of ganciclovir and trifluridine prevents drug-resistance emergence in
HSV-1.
Antimicrob Agents Chemother. 2024;68:e0011024.
PubMed
Abstract available
The Spx stress regulator confers high-level beta-lactam resistance and decreases
susceptibility to last-line antibiotics in methicillin-resistant Staphylococcus
aureus.
Antimicrob Agents Chemother. 2024 May 1:e0033524. doi: 10.1128/aac.00335.
PubMed
Abstract available
Role of tcaA, a potential target as a ceftobiprole resistance breaker, in MRSA
beta-lactam resistance.
Int J Antimicrob Agents. 2024 Apr 29:107185.
PubMed
Abstract available
Intravenous fosfomycin for treatment of severe infections caused by
carbapenem-resistant Acinetobacter baumannii: a multicenter clinical experience.
Int J Antimicrob Agents. 2024 Apr 30:107190.
PubMed
Abstract available
Increase of multidrug-resistant bacteria after the COVID-19 pandemic in a major
teaching Hospital in Sicily (2018-2021).
Int J Antimicrob Agents. 2024;63:107123.
PubMed
Abstract available
Evaluation of three brands of Mueller-Hinton media for broth microdilution method
to determine the susceptibility of multidrug-resistant Gram-negative bacilli
against eravacycline.
Int J Antimicrob Agents. 2024;63:107117.
PubMed
Levofloxacin-induced MexS mutation triggers imipenem-relebactam resistance in a
KPC-producing Pseudomonas aeruginosa.
Int J Antimicrob Agents. 2024;63:107119.
PubMed
Abstract available
Effectiveness and safety of minocycline combination therapy for the treatment of
patients with ventilator-associated pneumonia due to extensively drug- or
pandrug-resistant Acinetobacter baumannii.
Int J Antimicrob Agents. 2024;63:107129.
PubMed
Characterisation of cefiderocol-resistant spontaneous mutant variants of
Klebsiella pneumoniae-producing NDM-5 with a single mutation in cirA.
Int J Antimicrob Agents. 2024;63:107131.
PubMed
Intravenous fosfomycin in combination regimens as a treatment option for
difficult-to-treat infections due to multi-drug-resistant Gram-negative
organisms: A real-life experience.
Int J Antimicrob Agents. 2024;63:107134.
PubMed
Abstract available
Global distribution of bla(CMY-42), a gene mediating reduced susceptibility to
aztreonam-avibactam and ceftazidime-avibactam, in Escherichia coli.
Int J Antimicrob Agents. 2024;63:107141.
PubMed
Silent dissemination of fosfomycin resistance genes in critical-priority
Klebsiella pneumoniae.
Int J Antimicrob Agents. 2024;63:107139.
PubMed
ESBL-Escherichia coli extracellular vesicles mediate bacterial resistance to
beta-lactam and mediate horizontal transfer of bla(CTX-M-55).
Int J Antimicrob Agents. 2024;63:107145.
PubMed
Abstract available
Whole-genome sequencing identifies MprF mutations in a genetically diverse
population of daptomycin non-susceptible Staphylococcus aureus in Australia.
Int J Antimicrob Agents. 2024;63:107144.
PubMed
Abstract available
Spread and evolution of bla(KPC)-plasmid between Serratia marcescens and
Klebsiella pneumoniae.
Int J Antimicrob Agents. 2024;63:107149.
PubMed
Abstract available
Proteomics reveals that the antifungal activity of fenbendazole against
Cryptococcus neoformans requires protein kinases.
Int J Antimicrob Agents. 2024;63:107157.
PubMed
Abstract available
Fatal invasive pulmonary and cerebral aspergillosis due to triazole-resistant
Aspergillus fumigatus with multiple CYP51A mutations.
J Antimicrob Chemother. 2024 Feb 9:dkae038. doi: 10.1093.
PubMed
Pharmacodynamic evaluation of ceftriaxone single-dose therapy (0.125-1 g) to
eradicate ceftriaxone-susceptible and ceftriaxone-resistant Neisseria gonorrhoeae
strains in a hollow fibre infection model for gonorrhoea.
J Antimicrob Chemother. 2024;79:1006-1013.
PubMed
Abstract available
Impact of the phenotypic expression of temocillin resistance in Escherichia coli
on temocillin efficacy in a murine peritonitis model.
J Antimicrob Chemother. 2024;79:1051-1059.
PubMed
Abstract available
In vitro activity of apramycin (EBL-1003) in combination with colistin,
meropenem, minocycline or sulbactam against XDR/PDR Acinetobacter baumannii
isolates from Greece.
J Antimicrob Chemother. 2024;79:1101-1108.
PubMed
Abstract available
Comparison of the in vitro activities of delafloxacin and comparators against
Staphylococcus epidermidis clinical strains involved in osteoarticular
infections: a CRIOGO multicentre retrospective study.
J Antimicrob Chemother. 2024 Mar 20:dkae071. doi: 10.1093.
PubMed
Abstract available
Prevalence of pretreatment HIV resistance to integrase inhibitors in West African
and Southeast Asian countries.
J Antimicrob Chemother. 2024;79:1164-1168.
PubMed
Abstract available
Trends of pre-treatment drug resistance in antiretroviral-naive people with HIV-1
in the era of second-generation integrase strand-transfer inhibitors in Taiwan.
J Antimicrob Chemother. 2024;79:1157-1163.
PubMed
Abstract available
Drug resistance and influencing factors in HIV-1-infected individuals under
antiretroviral therapy in Guangxi, China.
J Antimicrob Chemother. 2024;79:1142-1152.
PubMed
Abstract available
Integrase strand transfer inhibitor resistance mediated by R263K plus E157Q in a
patient with HIV infection treated with bictegravir/tenofovir
alafenamide/emtricitabine: case report and review of the literature.
J Antimicrob Chemother. 2024;79:1153-1156.
PubMed
Abstract available
Collaborative Cross mice have diverse phenotypic responses to infection with
Methicillin-resistant Staphylococcus aureus USA300.
PLoS Genet. 2024;20:e1011229.
PubMed
Abstract available
Leveraging genomic signatures of oral microbiome-associated antibiotic resistance
genes for diagnosing pancreatic cancer.
PLoS One. 2024;19:e0302361.
PubMed
Abstract available
Thank you for your interest in scientific medicine.